The US FDA's drug evaluation department said on Friday it has formed a board to ​oversee and advise on exclusivity determinations made ‌by the department, aiming to improve clarity and consistency of those decisions.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in